Verastem Oncology
VSTM
#6555
Rank
โ‚น73.92 B
Marketcap
โ‚น586.60
Share price
-7.73%
Change (1 day)
-28.65%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -โ‚น18.35 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are โ‚น87.52 Million. In 2025 the company made an earning of -โ‚น19.42 Billion a decrease over its 2024 earnings that were of -โ‚น12.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น18.35 Billion-5.51%
2025 -โ‚น19.42 Billion60.57%
2024 -โ‚น12.09 Billion49.31%
2023 -โ‚น8.1 Billion18.36%
2022 -โ‚น6.85 Billion3.67%
2021 -โ‚น6.6 Billion5.43%
2020 -โ‚น6.26 Billion-54.74%
2019 -โ‚น13.83 Billion105.99%
2018 -โ‚น6.72 Billion6.83%
2017 -โ‚น6.29 Billion86.06%
2016 -โ‚น3.38 Billion-37.03%
2015 -โ‚น5.37 Billion8.43%
2014 -โ‚น4.95 Billion29.52%
2013 -โ‚น3.82 Billion28.6%
2012 -โ‚น2.97 Billion133.9%
2011 -โ‚น1.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น645.72 B-3,551.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น134.83 B-820.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น663.00 B-3,643.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-โ‚น0.79 Billion-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA